Medicsight on the Up - you have been told in Berkeley Square $4.72 soon $30

Now mgt




Equity Release
Media Contact: Javier E. David
American Stock Exchange
212-306-1440/javier.david@amex.com







AMERICAN STOCK EXCHANGE LISTS COMMON STOCK OF MEDICSIGHT INCORPORATED


New York, December 19, 2005 - The American Stock Exchange (Amex) today listed the common stock of Medicsight Incorporated., under the ticker symbol MGT.
Based in London, United Kingdom, the Company's primary business objective is to conceive, develop and commercialize innovative medical applications, such as computer-aided detection of disease, derived from its core technology through its majority-owned subsidiary, Medicsight PLC.

"As a growing company, we hope that Medicsight will find our services valuable as it seeks to garner more attention from the medical and investment communities," said John McGonegal, senior vice president of the Amex Equities Group. "Medicsight's listing at the Amex should be seen as a demonstration of our commitment to attracting more emerging companies based in Europe."

"We are delighted to move Medicsight onto the American Stock Exchange, which will bring our company's stock into a more liquid environment and increase our visibility to potential institutional investors," said David Mason, chief executive officer of Medicsight USA. "These enhancements to our visibility and trading liquidity come as we move Medicsight into a year of product commercialization and technology adoption."

The company has selected Cohen Specialists LLC as its specialist. For further information on MGT and other Amex-listed companies, please visit www.amex.com.